Illinois Hospital Report Card

and Consumer Guide to Health Care

Endeavor Evanston Hospital

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 4 infections, 95573 patient days Rating SIR: 0.58	4 infections, 95573 patient days	0.58
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 97608 patient days Rating SIR: 0.28	2 infections, 97608 patient days	0.28
Q1 2021 - Q4 2021 Result 3 infections, 102140 patient days Rating SIR: 0.48	3 infections, 102140 patient days	0.48
Q1 2020 - Q4 2020 Result 4 infections, 99844 patient days Rating SIR: 0.57	4 infections, 99844 patient days	0.57
Q1 2019 - Q4 2019 Result 5 infections, 92687 patient days Rating SIR: 1.07	5 infections, 92687 patient days	1.07
Q1 2018 - Q4 2018 Result 5 infections, 81106 patient days Rating SIR: 1.49	5 infections, 81106 patient days	1.49
Q1 2017 - Q4 2017 Result 1 infections, 78037 patient days Rating SIR: 0.26	1 infections, 78037 patient days	0.26
Q1 2016 - Q4 2016 Result 3 infections, 74061 patient days Rating SIR: 0.67	3 infections, 74061 patient days	0.67
Q1 2015 - Q4 2015 Result 1 infections, 77669 patient days Rating SIR: 0.25	1 infections, 77669 patient days	0.25
Q1 2014 - Q4 2014 Result 1 infections, 93043 patient days Rating SIR: 0.21	1 infections, 93043 patient days	0.21
Q1 2013 - Q4 2013 Result 2 infections, 96031 patient days Rating SIR: 0.38	2 infections, 96031 patient days	0.38
Q1 2012 - Q4 2012 Result 2 infections, 100191 patient days Rating SIR: 0.38	2 infections, 100191 patient days	0.38
Q1 2012 - Q2 2012 Result 1 infections, 50045 patient days Rating SIR: 0.20	1 infections, 50045 patient days	0.20
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 4 infections, 80398 patient days Rating SIR: 0.11	4 infections, 80398 patient days	0.11
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 14 infections, 82215 patient days Rating SIR: 0.28	14 infections, 82215 patient days	0.28
Q1 2021 - Q4 2021 Result 11 infections, 85180 patient days Rating SIR: 0.21	11 infections, 85180 patient days	0.21
Q1 2020 - Q4 2020 Result 15 infections, 82755 patient days Rating SIR: 0.30	15 infections, 82755 patient days	0.30
Q1 2019 - Q4 2019 Result 13 infections, 74585 patient days Rating SIR: 0.28	13 infections, 74585 patient days	0.28
Q1 2018 - Q4 2018 Result 14 infections, 62292 patient days Rating SIR: 0.37	14 infections, 62292 patient days	0.37
Q1 2017 - Q4 2017 Result 33 infections, 58873 patient days Rating SIR: 0.90	33 infections, 58873 patient days	0.90
Q1 2016 - Q4 2016 Result 33 infections, 55318 patient days Rating SIR: 0.95	33 infections, 55318 patient days	0.95
Q1 2015 - Q4 2015 Result 38 infections, 57230 patient days Rating SIR: 0.77	38 infections, 57230 patient days	0.77
Q1 2014 - Q4 2014 Result 35 infections, 73970 patient days Rating SIR: 0.55	35 infections, 73970 patient days	0.55
Q1 2013 - Q4 2013 Result 53 infections, 76517 patient days Rating SIR: 0.80	53 infections, 76517 patient days	0.80
Q1 2012 - Q4 2012 Result 74 infections, 80218 patient days Rating SIR: 1.03	74 infections, 80218 patient days	1.03